{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:49:34Z","timestamp":1793422174288,"version":"4.5.0"},"reference-count":123,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.biopsych.2013.01.007","type":"journal-article","created":{"date-parts":[[2013,2,18]],"date-time":"2013-02-18T16:12:20Z","timestamp":1361203940000},"page":"15-25","source":"Crossref","is-referenced-by-count":556,"title":["Cytokine Alterations in Bipolar Disorder: A Meta-Analysis of 30 Studies"],"prefix":"10.1016","volume":"74","author":[{"given":"Amirhossein","family":"Modabbernia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shervin","family":"Taslimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Brietzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandana","family":"Ashrafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2013.01.007_bib1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biopsych.2007.09.024","article-title":"Inflammatory cytokine alterations in schizophrenia: A systematic quantitative review","volume":"63","author":"Potvin","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2013.01.007_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2012.03.033","article-title":"Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: Randomized double-blind placebo-controlled study","volume":"141","author":"Abbasi","year":"2012","journal-title":"J Affect Disord"},{"key":"10.1016\/j.biopsych.2013.01.007_bib3","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1038\/npp.2012.58","article-title":"Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: Randomized double-blind placebo-controlled trial","volume":"37","author":"Sepanjnia","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2013.01.007_bib4","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/sj.mp.4001805","article-title":"The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: Results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine","volume":"11","author":"Muller","year":"2006","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2013.01.007_bib5","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2013.01.007_bib6","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.4088\/JCP.08r04505","article-title":"Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: A systematic review of the literature","volume":"70","author":"Goldstein","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2013.01.007_bib7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hup.912","article-title":"Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: A double-blind, randomized, placebo-controlled study","volume":"23","author":"Nery","year":"2008","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.biopsych.2013.01.007_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mehy.2010.08.021","article-title":"Therapeutic potential of interleukin-6 antagonism in bipolar disorder","volume":"76","author":"Brietzke","year":"2011","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.biopsych.2013.01.007_bib9","doi-asserted-by":"crossref","unstructured":"Brietzke E, Stabellini R, Grassis-Oliveira R, Lafer B (2011): Cytokines in bipolar disorder: Recent findings, deleterious effects but promise for future therapeutics [published online ahead of print July 1]. CNS Spectr.","DOI":"10.1017\/S1092852912000338"},{"key":"10.1016\/j.biopsych.2013.01.007_bib10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0165-0327(00)00252-4","article-title":"Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania","volume":"64","author":"Tsai","year":"2001","journal-title":"J Affect Disord"},{"key":"10.1016\/j.biopsych.2013.01.007_bib11","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1399-5618.2007.00493.x","article-title":"Immune variations in bipolar disorder: Phasic differences","volume":"9","author":"Ortiz-Dominguez","year":"2007","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.biopsych.2013.01.007_bib12","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jad.2008.12.001","article-title":"Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder","volume":"116","author":"Brietzke","year":"2009","journal-title":"J Affect Disord"},{"key":"10.1016\/j.biopsych.2013.01.007_bib13","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.pnpbp.2009.07.027","article-title":"The potential use of biomarkers as an adjunctive tool for staging bipolar disorder","volume":"33","author":"Kapczinski","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2013.01.007_bib14","first-page":"S36","article-title":"From neuroprogression to neuroprotection: Implications for clinical care","volume":"193","author":"Berk","year":"2010","journal-title":"Med J Aust"},{"key":"10.1016\/j.biopsych.2013.01.007_bib15","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.neubiorev.2010.10.001","article-title":"Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors","volume":"35","author":"Berk","year":"2011","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.biopsych.2013.01.007_bib16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jad.2004.01.007","article-title":"Cytokine production in bipolar affective disorder patients under lithium treatment","volume":"82","author":"Boufidou","year":"2004","journal-title":"J Affect Disord"},{"key":"10.1016\/j.biopsych.2013.01.007_bib17","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1399-5618.2005.00214.x","article-title":"Evidence that the immunopathogenic mechanism of lithium-induced psoriasis differs from that of regular psoriasis","volume":"7","author":"Knijff","year":"2005","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.biopsych.2013.01.007_bib18","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1399-5618.2007.00444.x","article-title":"An imbalance in the production of IL-1beta and IL-6 by monocytes of bipolar patients: Restoration by lithium treatment","volume":"9","author":"Knijff","year":"2007","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.biopsych.2013.01.007_bib19","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jad.2012.04.044","article-title":"Evidence for an association between tumor necrosis factor-alpha levels and lithium response","volume":"143","author":"Guloksuz","year":"2012","journal-title":"J Affect Disord"},{"key":"10.1016\/j.biopsych.2013.01.007_bib20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s12017-010-8140-8","article-title":"Mood disorders and obesity: Understanding inflammation as a pathophysiological nexus","volume":"13","author":"Soczynska","year":"2011","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.biopsych.2013.01.007_bib21","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jpsychires.2011.11.010","article-title":"Increased levels of adipokines in bipolar disorder","volume":"46","author":"Barbosa","year":"2012","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.biopsych.2013.01.007_bib22","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jad.2011.08.022","article-title":"Inflammatory markers and their relationships with leptin and insulin from acute mania to full remission in bipolar disorder","volume":"136","author":"Tsai","year":"2012","journal-title":"J Affect Disord"},{"key":"10.1016\/j.biopsych.2013.01.007_bib23","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jad.2012.02.016","article-title":"Towards a multifactorial approach for prediction of bipolar disorder in at risk populations","volume":"140","author":"Brietzke","year":"2012","journal-title":"J Affect Disord"},{"key":"10.1016\/j.biopsych.2013.01.007_bib24","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1017\/S1461145708009310","article-title":"Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder","volume":"12","author":"Kauer-Sant\u2019Anna","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2013.01.007_bib25","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1100\/tsw.2007.286","article-title":"Changes in allergy symptoms and depression scores are positively correlated in patients with recurrent mood disorders exposed to seasonal peaks in aeroallergens","volume":"7","author":"Postolache","year":"2007","journal-title":"Sci World J"},{"key":"10.1016\/j.biopsych.2013.01.007_bib26","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1001\/archpsyc.60.11.1125","article-title":"Mental disorders and asthma in the community","volume":"60","author":"Goodwin","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2013.01.007_bib27","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1176\/appi.ps.57.8.1140","article-title":"Medical comorbidity in bipolar disorder: Implications for functional outcomes and health service utilization","volume":"57","author":"McIntyre","year":"2006","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.biopsych.2013.01.007_bib28","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.4088\/JCP.09m05585ora","article-title":"A cohort study of the prevalence and impact of comorbid medical conditions in pediatric bipolar disorder","volume":"71","author":"Jerrell","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2013.01.007_bib29","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0006-3223(02)01452-X","article-title":"High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder","volume":"53","author":"Breunis","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2013.01.007_bib30","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0006-3223(98)00159-0","article-title":"Activation of indices of cell-mediated immunity in bipolar mania","volume":"45","author":"Tsai","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2013.01.007_bib31","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.bbi.2009.04.008","article-title":"Abnormalities in serum chemokine levels in euthymic patients with bipolar disorder","volume":"23","author":"Brietzke","year":"2009","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.biopsych.2013.01.007_bib32","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.bbi.2011.03.013","article-title":"The activation of monocyte and T cell networks in patients with bipolar disorder","volume":"25","author":"Drexhage","year":"2011","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.biopsych.2013.01.007_bib33","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1365-2265.2007.02963.x","article-title":"Insulin sensitivity, proinflammatory markers and adiponectin in young males with different subtypes of depressive disorder","volume":"67","author":"Hung","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.biopsych.2013.01.007_bib34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00406-010-0116-z","article-title":"Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder","volume":"261","author":"Barbosa","year":"2011","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.biopsych.2013.01.007_bib35","article-title":"Chemokines in bipolar disorder: Trait or state? [published online ahead of print May 15]","author":"Barbosa","year":"2012","journal-title":"Eur Arch Psychiatry Clin Neurosci."},{"key":"10.1016\/j.biopsych.2013.01.007_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/S0924-977X(09)70723-0","article-title":"The effect of mania on cytokine status in bipolar illness","volume":"19","author":"Remlinger","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2013.01.007_bib37","doi-asserted-by":"crossref","first-page":"S415","DOI":"10.1016\/S0924-977X(10)70597-6","article-title":"Cytokine profiles in bipolar affective disorder during acute episodes and in remission","volume":"20","author":"Remlinger-Molenda","year":"2010","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2013.01.007_bib38","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jad.2010.04.027","article-title":"Cytokine levels in euthymic bipolar patients","volume":"126","author":"Guloksuz","year":"2010","journal-title":"J Affect Disord"},{"key":"10.1016\/j.biopsych.2013.01.007_bib39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jad.2007.02.018","article-title":"Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder","volume":"104","author":"Kim","year":"2007","journal-title":"J Affect Disord"},{"key":"10.1016\/j.biopsych.2013.01.007_bib40","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jad.2005.11.015","article-title":"Cytokine profiles in bipolar affective disorder: focus on acutely ill patients","volume":"90","author":"O\u2019Brien","year":"2006","journal-title":"J Affect Disord"},{"key":"10.1016\/j.biopsych.2013.01.007_bib41","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0327(94)90012-4","article-title":"Immune parameters in euthymic bipolar patients and normal volunteers","volume":"32","author":"Rapaport","year":"1994","journal-title":"J Affect Disord"},{"key":"10.1016\/j.biopsych.2013.01.007_bib42","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0165-0327(01)00369-X","article-title":"Reduced production of interferon-gamma but not interleukin-10 in bipolar mania and subsequent remission","volume":"71","author":"Su","year":"2002","journal-title":"J Affect Disord"},{"key":"10.1016\/j.biopsych.2013.01.007_bib43","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jneuroim.2004.01.006","article-title":"Immunologic variables in acute mania of bipolar disorder","volume":"150","author":"Liu","year":"2004","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.biopsych.2013.01.007_bib44","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jpsychires.2011.08.003","article-title":"Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia","volume":"45","author":"Hope","year":"2011","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.biopsych.2013.01.007_bib45","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jpsychires.2010.05.015","article-title":"Peripheral biomarkers and illness activity in bipolar disorder","volume":"45","author":"Kapczinski","year":"2011","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.biopsych.2013.01.007_bib46","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0022-3956(94)00049-W","article-title":"Interleukin-2 and interleukin-6 in schizophrenia and mania: Effects of neuroleptics and mood stabilizers","volume":"29","author":"Maes","year":"1995","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.biopsych.2013.01.007_bib47","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0022-3956(99)00007-2","article-title":"Immune parameters in rapid cycling bipolar patients before and after lithium treatment","volume":"33","author":"Rapaport","year":"1999","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.biopsych.2013.01.007_bib48","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0022-3956(02)00103-6","article-title":"Plasma levels of soluble transferrin receptors and Clara cell protein (CC16) during bipolar mania and subsequent remission","volume":"37","author":"Tsai","year":"2003","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.biopsych.2013.01.007_bib49","first-page":"39","article-title":"The immunology of mood disorders: A comparison with healthy subjects and schizophrenics. Preliminary findings","volume":"11","author":"Di Michele","year":"1995","journal-title":"New Trend Exp Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2013.01.007_bib50","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.psychres.2004.08.005","article-title":"T-helper types 1, 2, and 3 cytokine interactions in symptomatic manic patients","volume":"129","author":"Kim","year":"2004","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2013.01.007_bib51","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1590\/S1516-44462011000300010","article-title":"Serum levels of IL-6, IL-10 and TNF-alpha in patients with bipolar disorder and schizophrenia: Differences in pro- and anti-inflammatory balance","volume":"33","author":"Kunz","year":"2011","journal-title":"Rev Bras Psiquiatr"},{"key":"10.1016\/j.biopsych.2013.01.007_bib52","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.immuni.2010.05.007","article-title":"Alternative activation of macrophages: Mechanism and functions","volume":"32","author":"Gordon","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.biopsych.2013.01.007_bib53","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol"},{"key":"10.1016\/j.biopsych.2013.01.007_bib54","first-page":"61","article-title":"The effector T helper cell triade","volume":"102","author":"Fietta","year":"2009","journal-title":"Riv Biol"},{"key":"10.1016\/j.biopsych.2013.01.007_bib55","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.jid.5700004","article-title":"Regulatory T cells","volume":"126","author":"Beissert","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.biopsych.2013.01.007_bib56","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1515\/REVNEURO.1993.4.4.407","article-title":"A review on the acute phase response in major depression","volume":"4","author":"Maes","year":"1993","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.biopsych.2013.01.007_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-1781(96)02915-0","article-title":"Acute phase proteins in schizophrenia, mania and major depression: Modulation by psychotropic drugs","volume":"66","author":"Maes","year":"1997","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2013.01.007_bib58","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.pnpbp.2007.02.018","article-title":"Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder","volume":"31","author":"Dickerson","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2013.01.007_bib59","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jad.2006.12.008","article-title":"Tryptophan breakdown pathway in bipolar mania","volume":"102","author":"Myint","year":"2007","journal-title":"J Affect Disord"},{"key":"10.1016\/j.biopsych.2013.01.007_bib60","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0893-133X(98)00058-X","article-title":"Serotonergic and noradrenergic markers of post-traumatic stress disorder with and without major depression","volume":"20","author":"Maes","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2013.01.007_bib61","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jad.2012.06.010","article-title":"Cytokines in bipolar disorder: A systematic review and meta-analysis","volume":"144","author":"Munkholm","year":"2013","journal-title":"J Affect Disord"},{"key":"10.1016\/j.biopsych.2013.01.007_bib62","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.biopsych.2013.01.007_bib63","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.biopsych.2013.01.007_bib64","unstructured":"Higgins J (2011): Green S. Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration. Available at: www.cochrane-handbook.org. Accessed February 3, 2013"},{"key":"10.1016\/j.biopsych.2013.01.007_bib65","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2214\/ajr.174.5.1741241","article-title":"A simple method for obtaining original data from published graphs and plots","volume":"174","author":"Sistrom","year":"2000","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.biopsych.2013.01.007_bib66","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2288-11-19","article-title":"A random effects variance shift model for detecting and accommodating outliers in meta-analysis","volume":"11","author":"Gumedze","year":"2011","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.biopsych.2013.01.007_bib67","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1590\/S0004-282X2012000100020","article-title":"[Peripheral biomarkers in bipolar disorder: A population-based study in young adults]","volume":"70","author":"Silva","year":"2012","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.biopsych.2013.01.007_bib68","article-title":"Central and peripheral immune activation in bipolar illness: Possible role of the chemokine CXCL5 in disease pathogenesis","volume":"65","author":"Quinones","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2013.01.007_bib69","article-title":"Upregulation of type i immune responses in the brain of individuals with bipolar disorder: Uncoupling of central and peripheral responses","volume":"65","author":"Quinones","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2013.01.007_bib70","article-title":"Differential involvement of inflammatory markers in adult and pediatric bipolar disorder","volume":"61","author":"Quinones","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2013.01.007_bib71","article-title":"Plasma TNF-RII as a new specific biomarker for the pathogenesis of bipolar disorder","volume":"61","author":"Quinones","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2013.01.007_bib72","article-title":"Levels of TNF-alpha, soluble TNF receptors (sTNFR1, sTNFR2) and cognitive impairment in bipolar disorder","volume":"14","author":"Doganavsargil-Baysal","year":"2012","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.biopsych.2013.01.007_bib73","article-title":"Tumor necrosis factor receptor-II (TNF-RII) a biomarker in bipolar disorder that links inflammation to cognitive dysfunction and neuroanatomical abnormalities","volume":"10","author":"Quinones","year":"2008","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.biopsych.2013.01.007_bib74","doi-asserted-by":"crossref","first-page":"S565","DOI":"10.1016\/S0924-977X(05)81184-8","article-title":"Plasma levels of tumor necrosis factor-alpha (TNF alpha) in first-episode bipolar disorder and schizophrenia patients","volume":"15","author":"Palomino","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2013.01.007_bib75","first-page":"1167","article-title":"The non-specific effect of lithium on interleukin 2 receptors (IL2Rs) and IL6Rs in lymphocytes of peripheral blood in bipolar mania type I","volume":"74","author":"Kirkby","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.biopsych.2013.01.007_bib76","article-title":"Brain-derived neurotrophic factor and inflammatory markers in patients with early-vs. late-state bipolar disorder","volume":"69","author":"Kauer-Sant\u2019Anna","year":"2011","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2013.01.007_bib77","article-title":"Serum levels of II6, II10 and TNF-alpha in patients with bipolar disorder in euthymia and with schizophrenia: Differences in pro and anti-inflammatory balance","volume":"67","author":"Kunz","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2013.01.007_bib78","article-title":"Altered profile of chemokines in patients with bipolar disorder type 1","volume":"71","author":"Teixeira","year":"2012","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2013.01.007_bib79","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1399-5618.2010.00822.x","article-title":"Similar immune profile in bipolar disorder and schizophrenia: Selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor","volume":"12","author":"Brietzke","year":"2010","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.biopsych.2013.01.007_bib80","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1399-5618.2009.00757.x","article-title":"Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor","volume":"11","author":"Hope","year":"2009","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.biopsych.2013.01.007_bib81","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1399-5618.2006.00359.x","article-title":"A relative resistance of T cells to dexamethasone in bipolar disorder","volume":"8","author":"Knijff","year":"2006","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.biopsych.2013.01.007_bib82","first-page":"6","article-title":"Increased plasma levels of soluble TNF-alpha receptors in bipolar disorder patients","volume":"12","author":"Barbosa","year":"2010","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.biopsych.2013.01.007_bib83","first-page":"10","article-title":"Comparison of cytokine levels in depressed, manic, and euthymic patients with bipolar disorder","volume":"12","author":"Brietzke","year":"2010","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.biopsych.2013.01.007_bib84","article-title":"Cytokine levels in euthymic bipolar patients","volume":"12","author":"Guloksuz","year":"2010","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.biopsych.2013.01.007_bib85","first-page":"84","article-title":"Plasma levels of TNF alpha in first-episode bipolar disorder and schizophrenia patients","volume":"7","author":"Palomino","year":"2005","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.biopsych.2013.01.007_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/S0924-977X(04)80096-8","article-title":"Th1, Th2 and Th3 cytokine alterations in bipolar disorder: Effects of mood stabilizers","volume":"14","author":"Kim","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2013.01.007_bib87","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1016\/S0924-977X(00)80157-1","article-title":"Effects of psychotropic agents on plasma levels of soluble interleukin-2 and interleukin-6 receptors in bipolar mania","volume":"10","author":"Lee","year":"2000","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2013.01.007_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/S0924-977X(10)70603-9","article-title":"No state-dependent alternation of immunological parameters, insulin, and leptin during bipolar depression","volume":"20","author":"Tsai","year":"2010","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2013.01.007_bib89","first-page":"213","article-title":"Inflammatory parameters and neurotrophic factors in bipolar disorder: searching trait and state biomarkers","volume":"60","author":"Teixeira","year":"2011","journal-title":"Inflamm Res"},{"key":"10.1016\/j.biopsych.2013.01.007_bib90","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jad.2011.12.034","article-title":"Executive dysfunction in euthymic bipolar disorder patients and its association with plasma biomarkers","volume":"137","author":"Barbosa","year":"2012","journal-title":"J Affect Disord"},{"key":"10.1016\/j.biopsych.2013.01.007_bib91","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0165-0327(02)00364-6","article-title":"Erratum to Reduced production of interferon-gamma but not interleukin-10 in bipolar mania and subsequent remission [J Affect Disord 2002;7:205\u2013209, PII: S016503270100369X]","volume":"73","author":"Su","year":"2003","journal-title":"J Affect Disord"},{"key":"10.1016\/j.biopsych.2013.01.007_bib92","article-title":"Cognitive function and plasma levels of neurotrophic and inflammatory parameters in patients with bipolar disorder","volume":"25","author":"Barbosa","year":"2011","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.biopsych.2013.01.007_bib93","first-page":"115","article-title":"Interleukin 1 receptor antagonist and tumor necrosis factor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder","volume":"37","author":"Hope","year":"2011","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.biopsych.2013.01.007_bib94","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/sj.mp.4001084","article-title":"The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: Effects of psychotropic drugs","volume":"7","author":"Kim","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2013.01.007_bib95","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.schres.2012.06.040","article-title":"Cardiovascular risk factors during second generation antipsychotic treatment are associated with increased C-reactive protein","volume":"140","author":"Dieset","year":"2012","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2013.01.007_bib96","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000339949","article-title":"Selected cytokine profiles during remission in bipolar patients","volume":"66","author":"Remlinger-Molenda","year":"2012","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.biopsych.2013.01.007_bib97","first-page":"599","article-title":"Activity of selected cytokines in bipolar patients during manic and depressive episodes [in Polish]","volume":"46","author":"Remlinger-Molenda","year":"2012","journal-title":"Psychiatr Pol"},{"key":"10.1016\/j.biopsych.2013.01.007_bib98","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2190\/PM.42.3.a","article-title":"Brain-derived neurotrophic factor, adiponectin, and proinflammatory markers in various subtypes of depression in young men","volume":"42","author":"Su","year":"2011","journal-title":"Int J Psychiatry Med"},{"key":"10.1016\/j.biopsych.2013.01.007_bib99","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1471-244X-12-158","article-title":"Plasma concentrations of soluble cytokine receptors in euthymic bipolar patients with and without subsyndromal symptoms","volume":"12","author":"Cetin","year":"2012","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.biopsych.2013.01.007_bib100","doi-asserted-by":"crossref","unstructured":"do Prado CH, Rizzo LB, Wieck A, Lopes RP, Teixeira AL, Grassi-Oliveira R, et al. (2012): Reduced regulatory T cells are associated with higher levels of Th1\/TH17 cytokines and activated MAPK in type 1 bipolar disorder [published online ahead of print September 14]. Psychoneuroendocrinology.","DOI":"10.1016\/j.psyneuen.2012.08.005"},{"key":"10.1016\/j.biopsych.2013.01.007_bib101","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2013.01.007_bib102","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/ni1263","article-title":"A function for interleukin 2 in Foxp3-expressing regulatory T cells","volume":"6","author":"Fontenot","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.biopsych.2013.01.007_bib103","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1172\/JCI23215","article-title":"IL-10-producing and naturally occurring CD4+ Tregs: Limiting collateral damage","volume":"114","author":"O\u2019Garra","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.biopsych.2013.01.007_bib104","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1096\/fj.99-1003rev","article-title":"The soluble interleukin 6 receptor: mechanisms of production and implications in disease","volume":"15","author":"Jones","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.biopsych.2013.01.007_bib105","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0167-4889(02)00319-1","article-title":"The role of soluble receptors in cytokine biology: The agonistic properties of the sIL-6R\/IL-6 complex","volume":"1592","author":"Jones","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.biopsych.2013.01.007_bib106","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1111\/j.1460-9568.1997.tb01705.x","article-title":"Activation of gp130 by IL-6\/soluble IL-6 receptor induces neuronal differentiation","volume":"9","author":"Marz","year":"1997","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2013.01.007_bib107","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/(SICI)1098-1136(199905)26:3<191::AID-GLIA1>3.0.CO;2-#","article-title":"Role of interleukin-6 and soluble IL-6 receptor in region-specific induction of astrocytic differentiation and neurotrophin expression","volume":"26","author":"Marz","year":"1999","journal-title":"Glia"},{"key":"10.1016\/j.biopsych.2013.01.007_bib108","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3109\/15622975.2010.518629","article-title":"Impaired nerve growth factor homeostasis in patients with bipolar disorder","volume":"12","author":"Barbosa","year":"2011","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2013.01.007_bib109","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1749-6632.2000.tb05398.x","article-title":"Cytokines and neurotrophins interact in normal and diseased states","volume":"917","author":"Otten","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.biopsych.2013.01.007_bib110","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1089\/cap.2011.0009","article-title":"Preliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders","volume":"21","author":"Goldstein","year":"2011","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.biopsych.2013.01.007_bib111","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.pnpbp.2012.07.013","article-title":"Reduced antioxidant defense systems in schizophrenia and bipolar I disorder","volume":"39","author":"Raffa","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2013.01.007_bib112","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s11064-010-0195-2","article-title":"Role of oxidative stress in the pathophysiology of bipolar disorder","volume":"35","author":"Steckert","year":"2010","journal-title":"Neurochem Res"},{"key":"10.1016\/j.biopsych.2013.01.007_bib113","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1601-183X.2008.00421.x","article-title":"Gray matter deficits in bipolar disorder are associated with genetic variability at interleukin-1 beta gene (2q13)","volume":"7","author":"Papiol","year":"2008","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.biopsych.2013.01.007_bib114","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/jmg.2003.012914","article-title":"Interleukin-1 cluster is associated with genetic risk for schizophrenia and bipolar disorder","volume":"41","author":"Papiol","year":"2004","journal-title":"J Med Genet"},{"key":"10.1016\/j.biopsych.2013.01.007_bib115","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/archpsyc.65.4.395","article-title":"A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes","volume":"65","author":"Padmos","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2013.01.007_bib116","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00041444-200409000-00009","article-title":"Impact of IL-1 receptor antagonist gene polymorphism on schizophrenia and bipolar disorder","volume":"14","author":"Kim","year":"2004","journal-title":"Psychiatr Genet"},{"key":"10.1016\/j.biopsych.2013.01.007_bib117","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.4049\/jimmunol.148.11.3578","article-title":"IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity","volume":"148","author":"Oswald","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.biopsych.2013.01.007_bib118","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.biopsych.2004.07.003","article-title":"A high prevalence of organ-specific autoimmunity in patients with bipolar disorder","volume":"56","author":"Padmos","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2013.01.007_bib119","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0022-3956(99)00021-7","article-title":"Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: Effects of confounding factors and diagnosis","volume":"33","author":"Haack","year":"1999","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.biopsych.2013.01.007_bib120","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.HYP.38.3.399","article-title":"Blood pressure and inflammation in apparently healthy men","volume":"38","author":"Chae","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.biopsych.2013.01.007_bib121","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1365-2265.2002.01629.x","article-title":"Serum concentrations of tumour necrosis factor-alpha (TNF-alpha) and soluble TNF-alpha receptor p55 in patients with hypothyroidism and hyperthyroidism before and after normalization of thyroid function","volume":"57","author":"Diez","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.biopsych.2013.01.007_bib122","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0140-6736(00)04170-2","article-title":"Effect of alcohol consumption on systemic markers of inflammation","volume":"357","author":"Imhof","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.biopsych.2013.01.007_bib123","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1042\/cs0880485","article-title":"Cigarette smoking influences cytokine production and antioxidant defences","volume":"88","author":"Tappia","year":"1995","journal-title":"Clin Sci (Lond)"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322313000474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322313000474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T15:48:29Z","timestamp":1688053709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322313000474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":123,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0006322313000474"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2013.01.007","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}